By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Grupo Ferrer Internacional S.A. 

c/o Gran Via Carles III
94-98 Entresuelo
Barcelona    08028  Spain
Phone: 34-0-93-3306111 Fax: 34-0-93-4908933


SEARCH JOBS








Company News
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014 9:21:33 AM
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria 10/24/2013 11:16:57 AM
Grupo Ferrer Internacional S.A. Successfully Completes an Absorption, Tolerability and Safety Study in Juveniles as Young as Two Months of Age for Novel Antibacterial Compound Ozenoxacin 10/5/2012 11:00:15 AM
Ferrer Submits IND for Arasertaconazole Nitrate, a Safe, Fast-Acting Topical Antifungal in Development for Vulvovaginal Candidiasis 8/8/2012 10:48:09 AM
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Amend Adasuve(TM) Partnership 3/8/2012 10:14:49 AM
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Establish $10 Million Partnership for the Commercialization of Adasuve(TM) (Staccato(R) Loxapine) in Europe and Latin America 10/6/2011 7:08:59 AM
Vasogen (VSGN) and Grupo Ferrer Internacional S.A. Announce Initial Roll-out of Celacade 12/17/2007 7:58:49 AM
Vasogen (VSGN) and Grupo Ferrer Internacional S.A. Form Collaboration to Commercialize Celacade(TM) in the European Union 4/18/2007 10:34:36 AM
NicOx SA (NCOX.F) And Grupo Ferrer Internacional S.A. Select Candidate For Development In Dermatology Collaboration 5/16/2006 10:36:17 AM
Barrier Therapeutics, Inc. (BTRX) Establishes European Commercialization Agreement Covering Four Products10/19/2005 5:12:03 PM
12
//-->